| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 3.101 | 86.283 | 100.062 | 171.416 | 134.379 |
| Total Income - EUR | - | - | - | 0 | 0 | 3.101 | 121.849 | 143.186 | 197.580 | 197.873 |
| Total Expenses - EUR | - | - | - | 496 | 50 | 2.931 | 101.347 | 127.733 | 182.314 | 191.611 |
| Gross Profit/Loss - EUR | - | - | - | -496 | -50 | 170 | 20.502 | 15.454 | 15.266 | 6.262 |
| Net Profit/Loss - EUR | - | - | - | -496 | -50 | 139 | 19.656 | 14.603 | 13.809 | 5.282 |
| Employees | - | - | - | 0 | 0 | 2 | 9 | 11 | 13 | 10 |
Check the financial reports for the company - Gb Soft Biotech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 2.006 | 108.441 | 110.285 | 98.356 | 73.099 | 123.118 |
| Current Assets | - | - | - | 0 | 63 | 7.212 | 63.634 | 93.842 | 153.245 | 113.775 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 20.781 | 29.210 |
| Receivables | - | - | - | 0 | 0 | 3.690 | 60.616 | 93.541 | 131.434 | 84.143 |
| Cash | - | - | - | 0 | 63 | 3.522 | 3.019 | 301 | 1.030 | 422 |
| Shareholders Funds | - | - | - | -453 | -494 | -342 | 19.322 | 33.133 | 46.841 | 23.290 |
| Social Capital | - | - | - | 43 | 42 | 45 | 44 | 45 | 44 | 44 |
| Debts | - | - | - | 453 | 2.564 | 115.995 | 131.571 | 153.424 | 179.503 | 213.604 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 23.027 | 5.641 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4312 - 4312" | |||||||||
| CAEN Financial Year |
812
|
|||||||||
Comments - Gb Soft Biotech S.r.l.